Clinical Trials Arena October 25, 2024
Akosua Mireku

At the Outsourcing in Clinical Trials Conference, key opinion leaders shared predictions for workflow changes due to AI.

As artificial intelligence (AI) permeates clinical trial operations more than ever, workforces will have to adapt to the changing tides, said experts at the recent Outsourcing in Clinical Trials New England conference.

The event, held from 23–24 October, gathered experts across the clinical trial industry to discuss the evolving landscape of AI in the pharmaceutical sector. “Our industries are terrible at adopting new technology,” says Manny Lazaro, the senior vice president of clinical operations and data management at the neuroscience biotech Cerevel Therapeutics. Lazaro highlighted the falling momentum behind major clinical trends such as decentralised clinical trials and the wave of eCOA...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Biotechnology, Clinical Trials, Conferences / Podcast, Pharma, Pharma / Biotech, Technology, Trends
Related Articles:
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Bariatric Surgeons Being Put Out of Work by GLP-1 Drugs
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Mark Cuban's 2025 plans
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025

Share This Article